Form D · Biotechnology

BigHat Biosciences, Inc.

San Mateo, CA · CIK 0001797256

Offering snapshot reported Oct 26, 2026 · SEC filing

Reported sold
$75.1M
Offering amount: $80M
Investors reported
29
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 17, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 26, 2026Initial$75,141,086No comparison29SEC filing
Apr 28, 2025Amendment$124,105,981$44,106,077vs Oct 3, 202240SEC filing
Oct 3, 2022Initial$79,999,904No comparison27SEC filing
Feb 12, 2021Initial$18,834,498No comparison6SEC filing
Dec 19, 2019Initial$5,302,511No comparison12SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-602529
Series C Preferred Stock and the Common Stock issuable upon conversion thereof.

Source: Form D, filed Oct 26, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Vineeta Agarwala Director
Robert Chess Director
Andrew Conrad Director
Mark De Pristo Director, Executive
Francisco Gimenez Director
Peyton Greenside Director, Executive
Steve Kafka Director
Theresa Tribble Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1900 Alameda De Las Pulgas Suite 400
San Mateo, CA, 94403